HOME >> BIOLOGY >> NEWS
Ribozymes To The Rescue: New UF Gene Therapy Shows Promise For Treatment Of Inherited Blindness

GAINESVILLE---University of Florida researchers have designed a new genetic weapon that can--in laboratory animals--significantly slow progression of retinitis pigmentosa, a leading cause of inherited human blindness.

The weapon, a ribozyme manufactured in the laboratory, works by chopping up genetic messengers before they deliver the instructions of a mutant gene.

"This is the first case we know of where ribozymes have been used to correct a disease in an animal in a way that realistically could be used in humans," said Alfred S. Lewin, a professor of molecular genetics and microbiology in UF's College of Medicine. "We also believe this technique might be useful for other inherited diseases."

Lewin and William Hauswirth, a professor with dual appointments in ophthalmology, as well as molecular genetics and microbiology, are leading a team conducting further animal studies in preparation for human clinical trials, an estimated five years away.

About 1 in 3,000 Americans has retinitis pigmentosa, a degenerative disease whose symptoms generally first appear during adolescence. As the disorder progresses, night vision, peripheral vision and ultimately all sight can be lost. Currently, there is no way to halt the deterioration.

Since the UF research was published in the August issue of Nature Medicine, Lewin has heard from many other scientists who are working to apply "ribozyme rescue" to heart disease, neurological disorders and viral diseases.

"UF's work is a great example of how fundamental research, whose goal is to understand basic cellular processes, can lead to important advances that have a direct impact on human health," said John Burke, a professor of microbiology and molecular genetics at the University of Vermont.

UF's research builds on the Nobel Prize-winning discovery in other laboratories that ribonucleic acid, or RNA, can act as an enzyme, a substance that causes chemical reactions within cells. It is then known as a ri
'"/>

Contact: Victoria White
vickiwhite@xtalwind.net
352-344-2738
University of Florida
9-Oct-1998


Page: 1 2 3

Related biology news :

1. Ribozymes Come Ready For Action
2. Interdisciplinary Method Offers New Way To Study Ribozymes
3. 1st International Conference on Cell Therapy for Cardiovascular Disease
4. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
5. Braunschweig Prize 2003 for Molecular Cancer Therapy
6. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
7. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
8. Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find
9. Invitation To Cover: American Society Of Gene Therapy Meeting
10. Gene Therapy For Pain
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... 17, 2020 , ... Commercial launch readiness is a critical stage in a ... cure or vaccine, the global economic downturn will only increase price pressures overall for ... and capturing full value from every product launch is critical. However, history shows that ...
(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics ... recognition and multiple awards for not only the products and treatments developed, but ... and Vivace® Microneedle RF. All the brands built by ABM have received several ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the ... clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... ... August 29, 2020 , ... ... Nutrition manufacturing capability in Wuxi, China. The new plant operation will provide the ... and advanced technology. , “This facility will improve the flexibility of our ...
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed ... prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique ... independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known ...
(Date:8/12/2020)... ... August 11, 2020 , ... Modality ... for free its new white paper – Simulated Transport Methodologies. Regulatory expectations ... biologics licensing application (BLA). In response, Modality Solutions shares an explanation of ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a ... has closed on the purchase of greenfield for a new, expanded manufacturing facility. ... over 21 acres in the initial acquisition, with an option to purchase an ...
Breaking Biology Technology:
Cached News: